aptamer GROUP Logo (WIPO, 06/29/2021)
WIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The International trademark aptamer GROUP was filed as Figurative mark on 06/29/2021 at the World Intellectual Property Organization.
Logodesign (Wiener Klassifikation)
#Armillary spheres, planetaria, astronomic orbits, atomic models, molecular models #Other polygons #Letters presenting a special form of writing #Colours #Atomic models, molecular models, representations of human, animal or vegetal cells #One polygon #Polygons containing other figurative elements #Series of letters presenting different forms of writing #Series of letters in different dimensions #Three predominant colours
| Trademark form | Figurative mark |
| File reference | 1659777 |
| Countries | 
|
| Base trademark |
No. UK00003625640,
April 13, 2021
|
| Application date | June 29, 2021 |
| Expiration date | June 29, 2031 |
Trademark owner
Second Floor, Bio Centre,
Innovation Way, Heslington
GB
Innovation Way, Heslington
GB
Trademark representatives
Calls Wharf,
2 The Calls
GB
goods and services
05
Pharmaceutical, medical and veterinary preparations;
medical, veterinary, diagnostic and pharmaceutical
preparations and materials; reagents (medical); chemical
reagents (medical); medical, veterinary, clinical,
diagnostic and pharmaceutical reagents, agents, chemicals,
materials, substances and preparations; medical, clinical,
diagnostic and pharmaceutical reagents, agents, chemicals,
materials, substances and preparations for medical and
veterinary use; optimised aptamer molecules for medical and
veterinary use; medical and veterinary diagnostic reagents
and assays for testing of body fluids; medical and
veterinary diagnostic test strips; diagnostic biomarker
reagents for medical and veterinary purposes; reagents and
media for medical and veterinary diagnostic or treatment
purposes; nucleic acids for medical, veterinary, diagnostic
and pharmaceutical purposes; nucleic acid sequences for
medical, veterinary, diagnostic and pharmaceutical purposes;
diagnostic testing kits (term considered too vague by the
International Bureau - Rule 13 (2) (b) of the Regulations);
diagnostic reagents for medical and veterinary use for sale
in kit form; diagnostic kits comprising specimen receptors
and reagents for medical, veterinary and diagnostic testing;
medical and veterinary diagnostic reagents and assays for
testing of fluids
10
Medical and veterinary apparatus, instruments, equipment,
tools and devices; diagnostic, examination and monitoring
apparatus, instruments, equipment, tools and devices (term
considered too vague by the International Bureau - Rule 13
(2) (b) of the Regulations); medical and veterinary
diagnostic apparatus, instruments, equipment, tools and
devices; diagnostic apparatus, instruments, equipment, tools
and devices for medical, veterinary and pharmaceutical
testing; diagnostic apparatus, instruments, equipment, tools
and devices for medical and veterinary purposes; medical and
veterinary diagnostic apparatus, instruments, equipment,
tools and devices for testing for viruses; apparatus,
instruments, equipment, tools and devices for carrying out
diagnostic tests for medical and veterinary purposes;
diagnostic testing kits (term considered too vague by the
International Bureau - Rule 13 (2) (b) of the Regulations);
parts and fittings for all the aforesaid goods
42
Research and development services (term considered too vague
by the International Bureau - Rule 13 (2) (b) of the
Regulations); design and development of diagnostic
apparatus, instruments, equipment, tools and devices;
research, design and development in the field of diagnostic
preparations; research, design and development of reagents;
research, design and development of aptamer reagents;
research, design and development of aptamer reagents for
integration into diagnostic platforms; research, design and
development of reagents for therapeutic applications;
research, design and development of aptamer reagents for
therapeutic applications; custom development of reagents;
custom development of aptamer reagents; optimsation of
aptamer molecules (term considered too vague by the
International Bureau - Rule 13 (2) (b) of the Regulations);
research, design and development of nucleic acids for
medical, veterinary, diagnostic and pharmaceutical purposes;
research, design and development of nucleic acid sequences
for medical, veterinary, diagnostic and pharmaceutical
purposes laboratory testing services; laboratory services
for analytical testing; design and development of testing
and analysis methods; preparation of biological samples for
testing and analysis in research laboratories; medical and
veterinary research services; medical and veterinary
laboratory services; scientific research and investigations
for medical and veterinary purposes; analysis of human and
animal tissues and samples for medical and veterinary
research; biological research, clinical research, medical
research and veterinary research; provision of information
and data relating to medical and veterinary research and
development; information and advisory services in respect of
the aforementioned services
44
Medical, veterinary and diagnostic services; medical and
veterinary testing services; medical and veterinary testing
for diagnostic or treatment purposes; medical and veterinary
analysis services for diagnostic and treatment purposes;
medical and veterinary testing services relating to
diagnosis and treatment; medical and veterinary analysis
services information and advisory services in respect of the
aforementioned services
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| July 28, 2023 | 2023/31 Gaz | RAW: Limitation | |
| June 19, 2023 | 2023/25 Gaz | MX | Rejection |
| May 15, 2023 | 2023/20 Gaz | KR | Rejection |
| May 4, 2023 | 2023/19 Gaz | VN | Rejection |
| April 16, 2023 | 2023/16 Gaz | RU | RAW: Rule 18ter(2)(i) GP following a provisional refusal |
| March 30, 2023 | 2023/13 Gaz | JP | Rejection |
| March 1, 2023 | 2023/9 Gaz | CN | Rejection |
| February 21, 2023 | 2023/11 Gaz | SG | Rejection |
| January 19, 2023 | 2023/4 Gaz | EM | RAW: Rule 18ter(2)(i) GP following a provisional refusal |
| October 5, 2022 | 2022/40 Gaz | BR | Rejection |
| August 26, 2022 | 2022/37 Gaz | NZ | Rejection |
| August 22, 2022 | 2022/34 Gaz | RU | Rejection |
| July 11, 2022 | 2022/37 Gaz | RAW: Limitation | |
| June 15, 2022 | 2022/24 Gaz | US | Rejection |
| June 6, 2022 | 2022/23 Gaz | IN | Rejection |
| May 11, 2022 | 2022/20 Gaz | AU | Rejection |
| May 11, 2022 | 2022/20 Gaz | EM | Rejection |
| June 29, 2021 | 2022/16 Gaz | GB | Registration |
ID: 141659777